子棕色脂肪组织的甲诱导的白化:勒素抵抗性和线粒体功能障碍
Xiaoqin Tang1, Beibei Zhang2, Puhang Xie2
1College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, 712100, P. R. China.
BMC genomics
|April 1, 2025
概括
像德克萨米他这样的葡萄皮质类药物诱导棕色脂肪组织 (BAT) 变成白色脂肪组织 (WAT) 的棕色化. 勒素耐药性通过影响线粒体功能,在这种代谢转变中起着关键作用.
科学领域:
- 代谢研究的研究.
- 内分泌学 在内分泌学.
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 外源性皮质糖类可以诱导诸如肥胖等代谢障碍.
- 了解葡萄糖皮质醇对棕色脂肪组织 (BAT) 的影响至关重要.
研究的目的:
- 调查葡萄糖皮质类药物,特别是德克萨米他 (Dex) 对BAT代谢转化为白色脂肪组织 (WAT) 的影响.
主要方法:
- 使用德甲 (Dex) 处理BAT.
- 评估脂质沉积,线粒体密度,ATP含量和线粒体标记表达.
- 分析瘦素受体 (LEPR) 表达及其在调解线粒体功能中的作用.
主要成果:
- 德甲治疗导致了BAT的显著变白.
- 观察到脂质沉积增加,线粒体密度降低,ATP含量降低,线粒体标志物表达率降低.
- 通过LEPR过度表达和抑制来调解线粒体功能的关键作用.
结论:
- 莱普耐药性与调节线粒体生物发生和能量代谢有关.
- 这项研究强调了勒素抵抗在葡萄糖皮质类药物诱导的棕色脂肪白色中所起的作用.
更多相关视频
04:46Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
Published on: February 3, 2023
1.2K
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
2.0K
相关概念视频
Inflammation
Overview
Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
